ZA805789B - Biologically active peptides - Google Patents
Biologically active peptidesInfo
- Publication number
- ZA805789B ZA805789B ZA00805789A ZA805789A ZA805789B ZA 805789 B ZA805789 B ZA 805789B ZA 00805789 A ZA00805789 A ZA 00805789A ZA 805789 A ZA805789 A ZA 805789A ZA 805789 B ZA805789 B ZA 805789B
- Authority
- ZA
- South Africa
- Prior art keywords
- biologically active
- active peptides
- peptides
- biologically
- active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7932590 | 1979-09-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA805789B true ZA805789B (en) | 1981-09-30 |
Family
ID=10507945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA00805789A ZA805789B (en) | 1979-09-20 | 1980-09-18 | Biologically active peptides |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPS5668651A (xx) |
BE (1) | BE885283A (xx) |
ZA (1) | ZA805789B (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59199663A (ja) * | 1983-04-27 | 1984-11-12 | Dainippon Pharmaceut Co Ltd | デルモルフイン誘導体 |
DE3514587A1 (de) * | 1985-04-23 | 1986-10-30 | Victor Dipl.-Chem. Dr.med. 6200 Wiesbaden Brantl | Pharmakologisch aktive peptide |
-
1980
- 1980-09-18 BE BE0/202142A patent/BE885283A/fr not_active IP Right Cessation
- 1980-09-18 JP JP13056780A patent/JPS5668651A/ja active Pending
- 1980-09-18 ZA ZA00805789A patent/ZA805789B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BE885283A (fr) | 1981-03-18 |
JPS5668651A (en) | 1981-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL61037A0 (en) | Biologically active peptides | |
PH15683A (en) | Immunopotentiating peptides | |
MY8500260A (en) | Biologically active peptides | |
PH17006A (en) | Pharmacollogically active peptides | |
JPS5697256A (en) | Pharmacutically active peptides | |
JPS5697255A (en) | Pharmacutically active peptides | |
JPS52125613A (en) | Biologically active composition | |
IL61703A0 (en) | Pharmacologically active peptides | |
IL61701A0 (en) | Pharmacologically active peptides | |
PT71087B (en) | Peptides having thymopoietin-like activity | |
AU557783B2 (en) | Biologically active peptides | |
GB2086396B (en) | Biologically active peptides | |
DE3264659D1 (en) | Biologically active peptides | |
ZA7855B (en) | Biologically active substance | |
JPS5718612A (en) | Biologically active mixture | |
ZA805789B (en) | Biologically active peptides | |
JPS5611795A (en) | Biologically active substance | |
JPS55149237A (en) | Thymopoietin active peptide | |
JPS55147250A (en) | Pankreozyminncholezystokinin active peptide* its manufacture and its intermediate | |
GB8309547D0 (en) | Biologically active peptides | |
JPS5677248A (en) | Peptides | |
IE811320L (en) | Biologically active peptides | |
JPS5391107A (en) | Biologically active substance | |
IE832922L (en) | Obtaining biologically active protein¹¹heterologous proteins | |
GB8423771D0 (en) | Biologically active peptides |